Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:49 UTC
Update Date2022-03-07 02:51:40 UTC
HMDB IDHMDB0014593
Secondary Accession Numbers
  • HMDB14593
Metabolite Identification
Common NameDroperidol
DescriptionA butyrophenone with general properties similar to those of haloperidol. It is used in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)
Structure
Data?1582753197
Synonyms
ValueSource
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinoneChEBI
1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinoneChEBI
1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-oneChEBI
1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-oneChEBI
DroperidolumChEBI
DroleptanKegg
InapsineKegg
Taylor brand OF droperidolHMDB
DehydrobenzperidolHMDB
Janssen brand OF droperidolHMDB
Kern brand OF droperidolHMDB
DehidrobenzperidolHMDB
Chemical FormulaC22H22FN3O2
Average Molecular Weight379.4274
Monoisotopic Molecular Weight379.169605168
IUPAC Name1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
Traditional Namedroperidol
CAS Registry Number548-73-2
SMILES
FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12
InChI Identifier
InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)
InChI KeyRMEDXOLNCUSCGS-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbonyl compounds
Direct ParentAlkyl-phenylketones
Alternative Parents
Substituents
  • Alkyl-phenylketone
  • Phenylbutylamine
  • Butyrophenone
  • Benzimidazole
  • Benzoyl
  • Aryl alkyl ketone
  • Halobenzene
  • Fluorobenzene
  • Aryl fluoride
  • Aryl halide
  • Monocyclic benzene moiety
  • Hydropyridine
  • Benzenoid
  • N-substituted imidazole
  • Gamma-aminoketone
  • Azole
  • Heteroaromatic compound
  • Imidazole
  • Urea
  • Tertiary aliphatic amine
  • Tertiary amine
  • Azacycle
  • Organoheterocyclic compound
  • Organonitrogen compound
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic nitrogen compound
  • Organofluoride
  • Organohalogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point145.75 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.097 g/LNot Available
LogP2.8Not Available
Experimental Chromatographic Properties

Experimental Collision Cross Sections

Adduct TypeData SourceCCS Value (Å2)Reference
[M+H]+Not Available195.041http://allccs.zhulab.cn/database/detail?ID=AllCCS00001320
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.097 g/LALOGPS
logP3.93ALOGPS
logP3.01ChemAxon
logS-3.6ALOGPS
pKa (Strongest Acidic)12.72ChemAxon
pKa (Strongest Basic)6.75ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area52.65 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity109.52 m³·mol⁻¹ChemAxon
Polarizability40.31 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-218.36730932474
DeepCCS[M+Na]+194.30830932474
AllCCS[M+H]+191.832859911
AllCCS[M+H-H2O]+189.132859911
AllCCS[M+NH4]+194.332859911
AllCCS[M+Na]+195.032859911
AllCCS[M-H]-191.632859911
AllCCS[M+Na-2H]-191.532859911
AllCCS[M+HCOO]-191.632859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
DroperidolFC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C124389.2Standard polar33892256
DroperidolFC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C123389.9Standard non polar33892256
DroperidolFC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C123590.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Droperidol,1TMS,isomer #1C[Si](C)(C)N1C(=O)N(C2=CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C213261.4Semi standard non polar33892256
Droperidol,1TMS,isomer #1C[Si](C)(C)N1C(=O)N(C2=CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C213099.3Standard non polar33892256
Droperidol,1TMS,isomer #1C[Si](C)(C)N1C(=O)N(C2=CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C214070.1Standard polar33892256
Droperidol,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)N(C2=CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C213419.5Semi standard non polar33892256
Droperidol,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)N(C2=CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C213313.1Standard non polar33892256
Droperidol,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)N(C2=CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C214097.4Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Droperidol GC-MS (Non-derivatized) - 70eV, Positivesplash10-05ir-3951000000-3ddcefbb8d45f9f67aea2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Droperidol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Droperidol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QTOF , positive-QTOFsplash10-001i-0209000000-83800a9c755f8223f3282017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QTOF , positive-QTOFsplash10-0006-0900000000-418e20f120e395aac71a2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QTOF , positive-QTOFsplash10-014i-0900000000-2888306b46b834e3dd3b2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QTOF , positive-QTOFsplash10-014i-0900000000-0cff909ec834cc05a2d32017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QTOF , positive-QTOFsplash10-00xr-0900000000-f910b21f009854002b172017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-001l-0609000000-b071b906d4d1f94ae8332017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-00kf-0900000000-ac3d815681b1b57a53b52017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-014i-0900000000-b2c3fb5ea6889dbf960c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-00xr-0900000000-01bdbb9758cd0acb88642017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-00di-0900000000-09ecdeee9f023e5ac6792017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-00di-0900000000-be69940105e80f5ab8692017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-00di-2900000000-9a55a536e908d62369242017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-00fr-9800000000-4462513b0f99ffd6ce932017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol LC-ESI-QFT , positive-QTOFsplash10-00b9-9200000000-b61d87593ee28d4b283e2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol , positive-QTOFsplash10-001i-0918000000-1efb9a7c97db08bb65d22017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol , positive-QTOFsplash10-014i-2900000000-dd5f00934e38a7c6ddbb2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol 40V, Positive-QTOFsplash10-014i-0900000000-5f95cf84340fd0c4ca822021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol 30V, Positive-QTOFsplash10-014i-0900000000-bc42cf9b86d45f887f432021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Droperidol 15V, Positive-QTOFsplash10-001l-0609000000-ad3c24202767f724c6c62021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Droperidol 10V, Positive-QTOFsplash10-001i-0119000000-d5120d98afdcbaa0059b2016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Droperidol 20V, Positive-QTOFsplash10-0019-0944000000-f0624282e21787fbbdd42016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Droperidol 40V, Positive-QTOFsplash10-000i-4921000000-fc1d95a1409cfea060f12016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Droperidol 10V, Negative-QTOFsplash10-004i-0109000000-36f79ce0bfee2b1fc2092016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Droperidol 20V, Negative-QTOFsplash10-0059-1519000000-e95399c58996c7c322642016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Droperidol 40V, Negative-QTOFsplash10-001i-2900000000-09ec31ccf84a44cf42f12016-08-03Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00450 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00450 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB00450
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID3056
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkDroperidol
METLIN IDNot Available
PubChem Compound3168
PDB IDNot Available
ChEBI ID4717
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Download (PDF)
General ReferencesNot Available

Enzymes

General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
This is one of the five types (D1 to D5) of receptors for dopamine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase
Gene Name:
DRD2
Uniprot ID:
P14416
Molecular weight:
50618.9
References
  1. Grip G, Svensson BA, Gordh T Jr, Post C, Hartvig P: Histopathology and evaluation of potentiation of morphine-induced antinociception by intrathecal droperidol in the rat. Acta Anaesthesiol Scand. 1992 Feb;36(2):145-52. [PubMed:1549935 ]
  2. Hamik A, Peroutka SJ: Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors. Cancer Chemother Pharmacol. 1989;24(5):307-10. [PubMed:2527092 ]
  3. Larson MD: The effect of antiemetics on pupillary reflex dilation during epidural/general anesthesia. Anesth Analg. 2003 Dec;97(6):1652-6. [PubMed:14633536 ]
  4. Gao HR, Shi TF, Yang CX, Zhang D, Zhang GW, Zhang Y, Jiao RS, Zhang H, Xu MY: The effect of dopamine on pain-related neurons in the parafascicular nucleus of rats. J Neural Transm (Vienna). 2010 May;117(5):585-91. doi: 10.1007/s00702-010-0398-3. Epub 2010 Apr 1. [PubMed:20358234 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins
Gene Name:
ADRA1A
Uniprot ID:
P35348
Molecular weight:
51486.0
References
  1. Zupko I, Janossy K, Maul K, Marki A, Falkay G: Alpha-adrenergic blockade: a possible mechanism of tocolytic action of certain benzodiazepines in a postpartum rat model in vivo. Life Sci. 2003 Jan 24;72(10):1093-102. [PubMed:12505540 ]